Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.

BACKGROUND Our objective was to assess the value of home blood pressure (BP) monitoring in comparison to office BP measurements and ambulatory monitoring in predicting hypertension-induced target-organ damage. METHODS Sixty-eight untreated patients with hypertension with at least two routine prestudy office visits were included (mean age, 48.6 +/- 9.1 [SD] years; 50 men). Office BP was measured in two study visits, home BP was measured for 6 workdays, and ambulatory BP was monitored for 24 h. All BP measurements were obtained using validated electronic devices. Target-organ damage was assessed by measuring the echocardiographic left-ventricular mass index (LVMI), urinary albumin excretion rate (AER) in two overnight urine collections, and carotid-femoral pulse-wave velocity (PWV) (Complior device; Colson, Garges-les-Gonesse, Paris, France). RESULTS The correlation coefficients of LVMI with office BP were 0.24/0.15 (systolic/diastolic), with home BP 0.35/0.21 (systolic, P < .01), and with 24-h ambulatory BP 0.23/0.19, awake 0.21/0.16, and asleep 0.28/0.26 (asleep, both P < .05). The correlation coefficients of AER with office BP were 0.24/0.31 (diastolic, P < .05), with home BP 0.28/0.26 (both P < .05), and with 24-h ambulatory BP 0.25/0.24, awake 0.24/0.25 (diastolic, P < .05), and asleep 0.26/0.18 (systolic, P < .05). There was a trend for negative correlations between PWV and diastolic BP measurements (not significant). In multiple-regression models assessing independent predictors of each of the three indices of target-organ damage, systolic home BP and age were the only independent predictors of increased LVMI that reached borderline statistical significance. CONCLUSIONS These data suggest that home BP is as reliable as ambulatory monitoring in predicting hypertension-induced target-organ damage, and is superior to carefully taken office measurements.

[1]  G. Stergiou,et al.  White coat effect detected using self-monitoring of blood pressure at home: comparison with ambulatory blood pressure. , 1998, American journal of hypertension.

[2]  G. Jensen,et al.  New Definition of Microalbuminuria in Hypertensive Subjects: Association With Incident Coronary Heart Disease and Death , 2005, Hypertension.

[3]  J. Staessen,et al.  The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies , 1995, Journal of hypertension.

[4]  J. Blacher,et al.  Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure , 2001, Circulation.

[5]  O. Matsuoka,et al.  Weekly Variation of Home and Ambulatory Blood Pressure and Relation Between Arterial Stiffness and Blood Pressure Measurements in Community-Dwelling Hypertensives , 2005, Clinical and experimental hypertension.

[6]  B. Pannier,et al.  Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study. , 2001, Journal of hypertension.

[7]  Giuseppe Mancia,et al.  Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy , 1997 .

[8]  J. Staessen,et al.  Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. A metaanalysis of comparative studies. , 1995, American journal of hypertension.

[9]  J. Kastrup,et al.  Microalbuminuria: an early marker of renal involvement in diabetes. , 1985, Uremia investigation.

[10]  G. Stergiou,et al.  Cardiovascular risk prediction based on home blood pressure measurement: The Didima Study , 2007, Journal of hypertension.

[11]  Teresa Sancho,et al.  Home blood pressure in poorly controlled hypertension: relationship with ambulatory blood pressure and organ damage , 2006, Blood pressure monitoring.

[12]  George S. Stergiou,et al.  Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. , 2001, American journal of hypertension.

[13]  R. Asmar,et al.  Arterial stiffness and blood pressure self-measurement with loaned equipment. , 2003, American journal of hypertension.

[14]  J. Staessen,et al.  Characteristics of conventional blood pressure in studies on the predictive power of ambulatory blood pressure , 2002, Blood pressure monitoring.

[15]  Gianfranco Parati,et al.  Self monitoring of blood pressure at home , 2004, BMJ : British Medical Journal.

[16]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .

[17]  T. Ohkubo,et al.  Proposal of reference values for home blood pressure measurement: prognostic criteria based on a prospective observation of the general population in Ohasama, Japan. , 1997, American journal of hypertension.

[18]  Roberto Sega,et al.  Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.

[19]  Yutaka Imai,et al.  European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement , 2003, Journal of hypertension.

[20]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[21]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[22]  G Chatellier,et al.  Self blood pressure measurement at home. , 1993, Clinical and experimental hypertension.

[23]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[24]  G. Stergiou How to cope with unreliable office blood pressure measurement? , 2005, American journal of hypertension.

[25]  2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2004, Heart Drug.

[26]  Gilles Chatellier,et al.  Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients , 2004 .

[27]  G. Stergiou,et al.  Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? , 2005, American journal of hypertension.

[28]  J. Redón,et al.  Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability , 1994, Journal of hypertension.

[29]  P. Palatini,et al.  Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension , 1995, Journal of hypertension.

[30]  Giuseppe Andronico,et al.  Value of Home Blood Pressures as Predictor of Target Organ Damage in Mild Arterial Hypertension , 2002, Journal of cardiovascular risk.

[31]  B. Williams,et al.  Microalbuminuria in essential hypertension: redefining the threshold. , 2002, Journal of hypertension.

[32]  G Mancia,et al.  Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. , 1997, Circulation.

[33]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[34]  P. Okin,et al.  Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE Study , 2006, Journal of hypertension.